Abstract
Silencing of gene expression by small interfering RNAs (siRNAs) is rapidly becoming a powerful tool for genetic analysis and represents a potential strategy for therapeutic product development. However, there are no reports of systemic delivery for siRNAs toward treatment of bone-metastatic cancer. Accordingly, we report here that i.v. injection of GL3 luciferase siRNA complexed with atelocollagen showed effective reduction of luciferase expression from bone-metastatic prostate tumor cells developed in mouse thorax, jaws, and/or legs. We also show that the siRNA/atelocollagen complex can be efficiently delivered to tumors 24 h after injection and can exist intact at least for 3 days. Furthermore, atelocollagen-mediated systemic administration of siRNAs such as enhancer of zeste homolog 2 and phosphoinositide 3′-hydroxykinase p110-α-subunit, which were selected as candidate targets for inhibition of bone metastasis, resulted in an efficient inhibition of metastatic tumor growth in bone tissues. In addition, upregulation of serum IL-12 and IFN-α levels was not associated with the in vivo administration of the siRNA/atelocollagen complex. Thus, for treatment of bone metastasis of prostate cancer, an atelocollagen-mediated systemic delivery method could be a reliable and safe approach to the achievement of maximal function of siRNA.
Bibliography
Takeshita, F., Minakuchi, Y., Nagahara, S., Honma, K., Sasaki, H., Hirai, K., Teratani, T., Namatame, N., Yamamoto, Y., Hanai, K., Kato, T., Sano, A., & Ochiya, T. (2005). Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proceedings of the National Academy of Sciences, 102(34), 12177â12182.
Authors
13
- Fumitaka Takeshita (first)
- Yoshiko Minakuchi (additional)
- Shunji Nagahara (additional)
- Kimi Honma (additional)
- Hideo Sasaki (additional)
- Kotaro Hirai (additional)
- Takumi Teratani (additional)
- Nachi Namatame (additional)
- Yusuke Yamamoto (additional)
- Koji Hanai (additional)
- Takashi Kato (additional)
- Akihiko Sano (additional)
- Takahiro Ochiya (additional)
References
37
Referenced
309
10.1038/nature02870
10.1038/418038a
10.1038/ng944
10.1016/S1535-6108(02)00122-8
10.1038/nbt739
10.1016/S0022-2836(03)00181-5
10.1261/rna.5239604
10.1038/nature03121
- Verma, U. N., Surabhi, R. M., Schmaltieg, A., Becerra, C. & Gaynor, R. B. (2003) Clin. Cancer Res. 9, 1291-1300.12684397 / Clin. Cancer Res. (2003)
- Filleur, S., Courtin, A., Ait-Si-Ali, S., Guglielmi, J., Merle, C., Harel-Bellan, A., Clezardin, P. & Cabon, F. (2003) Cancer Res. 63, 3919-3922.12873985 / Cancer Res. (2003)
10.1016/j.bbrc.2003.10.060
10.1038/sj.onc.1207247
10.1093/jnci/djh146
10.1038/9560
10.1006/bbrc.2001.6133
10.2174/1566523013348887
10.1002/jgm.440
10.1016/j.addr.2003.08.005
10.1089/104303404322886110
-
Minakuchi, Y., Takeshita, F., Kosaka, N., Sasaki, H., Yamamoto, Y., Kouno, M., Honma, K., Nagahara, S., Hanai, K., Sano, A., et al. (2004) Nucleic Acids Res. 32, e109.15272050
(
10.1093/nar/gnh093
) / Nucleic Acids Res. (2004) 10.1158/0008-5472.CAN-03-2682
10.1146/annurev.bb.03.060174.001311
10.1038/35078107
- Arguello, F., Furlanetto, R. W., Baggs, R. B., Graves, B. T., Harwell, S. E., Cohen, H. J. & Frantz, C. N. (1992) Cancer Res. 52, 2304-2309.1559233 / Cancer Res. (1992)
10.1023/B:CLIN.0000006817.25962.87
10.1023/B:CLIN.0000006815.49932.98
- Scanlon, K. J. (2004) Anticancer Res. 24, 501-504.15152950 / Anticancer Res. (2004)
10.1016/j.bbrc.2003.11.057
10.1038/nbt831
10.1038/ng1173
10.1038/nbt1038
10.2165/00003088-200342130-00002
10.1038/nm1002
10.1038/nature01075
10.1146/annurev.cellbio.17.1.615
10.1073/pnas.1933744100
10.4161/cbt.3.8.994
Dates
Type | When |
---|---|
Created | 20 years ago (Aug. 9, 2005, 10:53 p.m.) |
Deposited | 3 years, 4 months ago (April 12, 2022, 2:21 p.m.) |
Indexed | 4 days ago (Aug. 26, 2025, 2:29 a.m.) |
Issued | 20 years ago (Aug. 9, 2005) |
Published | 20 years ago (Aug. 9, 2005) |
Published Online | 20 years ago (Aug. 9, 2005) |
Published Print | 20 years ago (Aug. 23, 2005) |
@article{Takeshita_2005, title={Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo}, volume={102}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.0501753102}, DOI={10.1073/pnas.0501753102}, number={34}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Takeshita, Fumitaka and Minakuchi, Yoshiko and Nagahara, Shunji and Honma, Kimi and Sasaki, Hideo and Hirai, Kotaro and Teratani, Takumi and Namatame, Nachi and Yamamoto, Yusuke and Hanai, Koji and Kato, Takashi and Sano, Akihiko and Ochiya, Takahiro}, year={2005}, month=aug, pages={12177–12182} }